The document discusses intellectual property, patents, and the patent system as it relates to the pharmaceutical industry. It defines intellectual property and patents, noting that patents provide exclusive rights for a limited time. It outlines criteria for patentability including novelty, inventiveness, and commercial value. It states that the pharmaceutical sector is a major user of patents to protect drugs and restrain competition. However, the patent system can sometimes block competition and require medical inventions to undergo clinical testing.

1. Presented by- ANSH DEV
A45133009001

2.  INTELLECTUAL PROPERTY
 DISCOVERY,INVENTION & INNOVATION
 PATENT
 CRITERIA FOR PATENTIBLITY
 NON PATENTABLE
 PATENT SYSTEM IN PHARMACEUTICAL
INDUSTRY
 PROBLEMS OF PHARMACEUTICAL
PATENTS

3.  CREATION OF
MIND
 INTANGIBLE
INCORPORATE
PROPERTY
 IMBIBED FROM THE
INTELLECTUAL
CAPACITY
FOR WHICH
PROPERTY RIGHTS
ARE RESERVED

4.  DISCLOSURE
 CREATION
OF A NEW
PRODUCT/PROCE
SS
 ADDING TO
THE VALUE
OF AN
EXISTING
PROUCT

5. SET OF EXCLUSIVE
RIGHTS
SUBJECT TO
NATIONAL LAWS
AND
INTERNATIONAL
AGREEMENTS

6.  DIFFERENT FOR
DIFFERENT
COUNTRIES
 HAVING A SPECIFIC
DURATION
 A PRECURSER OF THE
MODERN COPYRIGHT

7.  NOVELTY
 INVENTIVENES
S
 COMMERCIAL
VALUE

8.  METHOD OF AGRICULTURE
 A PROCESS OF MEDICINAL,SURGICAL OR
CURATIVE TREATMENT
 PLANTS AND ANIMAL AS A WHOLE OR A
SPECIFIC PART OF IT ( MICRO
EX
ORGANISMS)
 A MATHEMATICAL METHOD
 A
LITERARY,DRAMATIC,MUSICAL/ARTISTIC
WORK
 A PRESENTATION OF INFORMATION
 INVENTION RELATED TO ATOMIC ENERGY

9.  PHARMACEUTICAL SECTOR MAJOR
USER OF PATENT SYSTEM
 THOUSANDS OF APPLICATIONS ARE
FILED ANNUALLY
 USED TO RESTRAIN COMPETITION AS
PATENT GRANT EXCLUSIVE RIGHTS
REGARDING THE SALE,PRODUCTION &
USE OF THE PATNTED MATTER
 THOROUGH STUDIES ARE CARRIED
OUT BEFORE GRANTING A
PHARMACEUTICAL PATENT

10.  EARLY DISCLOSURE OF INVENTION
 UNDER GOVERNMENT INFLUENCE
 MEDICALINVENTION ARE
REQUIRED TO UNDERGO A STRICT
REGIME OF CLINICAL TESTS

11. o WHETHER SUBJECT TO TRIPS
AGREEMENT OR NOT, COUNTRIES CAN
DETERMINE THEIR OWN CRITERIA TO
ASSESS PATENT APPLICATION
o PATENT SYSTEM CAN SOMETIMES BE
USED TO BLOCK COMPETETION
o ONLY INVENTIONS HAVING A
COMMERCIAL VALUE, REQUIRING AN
INVENTIVE STEP AND POSSESSING
NOVELTY CAN BE PATENTED
o PHARMA SECTOR IS A MAJOR USER OF
PATENT SYSTEM

12. DR. AJIT VERMA
DIRECTOR, AMITY
INSTITUTE OF
MICROBIAL SCIENCES,
Discoveror of a fungi for
which Amity has a patent.